Publicaciones en las que colabora con Catuxa Prado Cueto (10)

2014

  1. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Relationship between FOXP3 positive populations and cytokine production in systemic lupus erythematosus

    Cytokine, Vol. 61, Núm. 1, pp. 90-96

2012

  1. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 51, Núm. 10, pp. 1775-1784

  2. Effects of glucocorticoid treatment on CD25 -FOXP3 + population and cytokine-producing cells in rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 51, Núm. 7, pp. 1198-1207

2011

  1. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity

    Immunobiology, Vol. 216, Núm. 3, pp. 386-392

  2. Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients

    Rheumatology, Vol. 50, Núm. 10, pp. 1794-1801

2010

  1. Cytokines and regulatory T cells in rheumatoid arthritis and their relationship with response to corticosteroids

    Journal of Rheumatology, Vol. 37, Núm. 12, pp. 2502-2510

  2. Interleukin 10 and tumor necrosis factor-α genotypes in rheumatoid arthritis - Association with clinical response to glucocorticoids

    Journal of Rheumatology, Vol. 37, Núm. 3, pp. 503-511

2009

  1. Conserved anti-proliferative effect and poor inhibition of TNFα secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus

    Clinical Immunology, Vol. 132, Núm. 3, pp. 385-392

2008

  1. Influence of functional interleukin 10/tumor necrosis factor-α polymorphisms on interferon-α, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment

    Journal of Rheumatology, Vol. 35, Núm. 8, pp. 1559-1566